Currently, the share price for Eris Lifesciences Ltd. is delayed. Login to view live prices.
Eris Lifesciences Ltd.
₹1,290.15
NSE
-- ( -- %) 1D
- Prev. Close1,290.15
- Upper Circuit1,548.15
- Lower Circuit1,032.15
Analyst Sentiment For Eris Lifesciences Ltd.
As recommended by 11 analysts
Returns
Eris Lifesciences Ltd.'s Info & Management
ERIS Lifesciences manufactures, markets, and sells generic drugs the Company provides a wide range of products in chronic and acute therapy segments which includes capsules, tablets, and sachets. Eris Lifesciences also focuses on hypertension, anti-diabetes, metabolic disorders, lipid lowering, and therapeutic areas. Eris Lifesciences serves the pharmaceutical markets in India
- President(Sales & Marketing)Gagan Atreja
- Chief Financial OfficerSachin Shah
- Vice PresidentManish Kapoor
- Senior Vice PresidentDeepak Kapoor
- President(Medical)Vijay S. Joshi
- Vice PresidentSantanu Rudra
FAQs on Eris Lifesciences Ltd.
What is the share price of Eris Lifesciences Ltd.?
Eris Lifesciences Ltd. share price is ₹1,289.20 as of January 20, 2025, 03:29 PM. Share/stock prices are volatile and change over the course of a trading day, and may differ basis on exchange (NSE/BSE).
What is the 52-week high and low of Eris Lifesciences Ltd.?
The 52-week high and low of Eris Lifesciences Ltd. is ₹1,593.70 and ₹810.65 respectively as of January 20, 2025, 03:29 PM.
52-week high and low represent the maximum and minimum value of the share price respectively, over the last 52 weeks (similar to 1 year).
What is the PB ratio of Eris Lifesciences Ltd.?
The trailing twelve month (TTM) PB ratio of Eris Lifesciences Ltd. is 6.79 as of January 20, 2025. The PB ratio measures the market capitalization of the company relative to it’s book value (carrying value on the balance sheet) as of last reported period.
What are the Upper Circuit and Lower Circuit of Eris Lifesciences Ltd.?
The Upper Circuit of Eris Lifesciences Ltd. is ₹1,548.
The Lower Circuit of Eris Lifesciences Ltd. is ₹1,032.
What is the ROE of Eris Lifesciences Ltd.?
Eris Lifesciences Ltd. reported an ROE of 16.39% for the last reported financial year on a consolidated account basis. Return on Equity (ROE) reflects how efficiently the company is able to generate profit as a percent of their equity financing.
What is the shareholding pattern of Eris Lifesciences Ltd.?
Shareholding pattern gives insights on the concentration of holdings towards various groups of investors. As of last reported quarter for Eris Lifesciences Ltd., Promoter held 54.9%, the FII held 8%, DII held 18.6% and the public held 18.5% of the total shares.
How to buy Eris Lifesciences Ltd. Share?
You can easily buy shares of Eris Lifesciences Ltd. online through Share.Market. If you are an existing user, login to your account, else follow the process to create your own Demat and Trading account in a few easy steps.
What is the fair value of Eris Lifesciences Ltd.?
The fair value of Eris Lifesciences Ltd. is an estimated price at which buyers and sellers would freely trade their shares. The various ways to determine the fair value of an asset include looking at recent market transactions for similar assets, estimating its expected earnings or the cost of replacing it.
Trademarks owned by their respective owners and shown here only for ease of recall of the respective owner by public.Disclaimer